Today: 25 June 2026
Browse Category

ISE:BIRG 24 November 2025

Ireland Stock Market Today, 24 November 2025: ISEQ Rebounds Above 12,300 as Bank Stocks and Ryanair Drive Gains

Ireland Stock Market Today, 24 November 2025: ISEQ Rebounds Above 12,300 as Bank Stocks and Ryanair Drive Gains

The ISEQ All-Share closed Monday at 12,308.94, up 1.05%, rebounding with European markets on hopes of US rate cuts and optimism over Ukraine talks. The ISEQ Financial index jumped 1.8%, led by Bank of Ireland up 2.65% to €15.69. AIB rose 1.4%, and Permanent TSB gained 1.25%. The advance follows last week’s sharp tech-driven sell-off.
24 November 2025

Stock Market Today

  • Moonpig shares deemed 'crazy cheap' after full-year results beat forecasts
    June 25, 2026, 11:23 AM EDT. Moonpig Group PLC reported a strong 2026 financial year with adjusted EBITDA of £104.6 million and pre-tax profit of £76.5 million, slightly exceeding expectations. Revenue rose 6.5% to £373 million, driven by an 8.6% growth in its core business and recovery in its Dutch subsidiary Greetz. Despite a 4.5% drop in its Experiences division, brokers Jefferies and Panmure Liberum reiterated 'buy' ratings, citing the shares' attractive valuation with a 9% free cash flow yield. Jefferies noted concerns over slowing growth are already priced in, maintaining a 315p target price that implies 40% upside. Moonpig lowered its medium-term revenue growth outlook to mid-to-high single digits but expects double-digit earnings per share growth, with trading so far aligning with guidance.

Latest News

US stocks now: Broad gains balance $416 billion drop in megacap tech

US stocks now: Broad gains balance $416 billion drop in megacap tech

25 June 2026
Apple, Nvidia, Microsoft, Alphabet, and Meta lost about $416 billion in combined market value as investors rotated into Dow and small-cap stocks, with Apple dragging after raising MacBook and iPad prices due to higher memory costs; meanwhile, Micron surged 10.4% on strong earnings and guidance, and Qualcomm gained 3.6% after boosting long-term revenue targets.
Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

25 June 2026
Bio-Techne surged 19% to $70.17 after Merck KGaA’s $73 per share cash offer, leaving a $2.83 spread as the deal awaits shareholder and regulatory approval, with closing expected in late 2026 or early 2027; trading volume soared past short interest, and the deal values Bio-Techne at $11.3 billion, less than 9.4 times fiscal 2025 sales.
Go toTop